2006
Epistaxis and severe weakness in a patient with multiple myeloma. Therapy-related acute myeloid leukemia, pure erythroid leukemia. Arch Pathol Lab Med. 2006;130(7):1075-6.
Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma. Clin Cancer Res. 2006;12(19):5622-31.
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas. Blood. 2006;107(2):689-97.
A kinase-independent function of c-Abl in promoting proteolytic destruction of damaged DNA binding proteins. Mol Cell. 2006;22(4):489-99.
Hydration of the folding transition state ensemble of a protein. Biochemistry. 2006;45(11):3473-80.
Defining cell lineages in the prostate epithelium. Cell Cycle. 2006;5(2):138-41.
Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. Mod Pathol. 2006;19 Suppl 2:S71-87.
Pathology of B-cell non-Hodgkin's lymphomas and multiple myeloma. Cancer Treat Res. 2006;131:1-48.
p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling. Cancer Res. 2006;66(17):8529-41.